Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states

Neuropharmacology

Volumn 96, Issue PB, 2015, Pages 235-243

  Picciotto, Marina R ^a   Lewis, Alan S ^a   Van Schalkwyk, Gerrit I ^a   Mineur, Yann S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aggression; Behavior; Depression; Mood disorders; Nicotine; Nicotinic acetylcholine receptors; Smoking; Withdrawal

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DEXMECAMYLAMINE; HEXAMETHONIUM; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR BLOCKING AGENT; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AGGRESSION; AGGRESSION RELATED BEHAVIORAL STATE; AGITATION; ANTIDEPRESSANT ACTIVITY; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DEMENTIA; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GILLES DE LA TOURETTE SYNDROME; HUMAN; MOOD DISORDER; NEUROTRANSMISSION; NONHUMAN; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SMOKING; SMOKING CESSATION; AFFECT; ANIMAL; ANXIETY; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

AFFECT; AGGRESSION; ANIMALS; ANXIETY; CLINICAL TRIALS AS TOPIC; HUMANS; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 84932198665     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.12.028     Document Type: Review

References (148)

1. M. al'Absi, S.B. Carr, and S. Bongard Anger and psychobiological changes during smoking abstinence and in response to acute stress: prediction of smoking relapse Int. J. Psychophysiol. 66 2007 109 115
2. M.H. Allen, M. Debanne, C. Lazignac, E. Adam, L.M. Dickinson, and C. Damsa Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study Am. J. Psychiatry 168 2011 395 399
3. L.H. Allikmets, V.A. Vahing, and I.P. Lapin Dissimilar influences of imipramine, benactyzine and promazine on effects of micro-injections of noradrenaline, acetylcholine and serotonin into the amygdala in the cat Psychopharmacologia 15 1969 392 403
4. C.S. Amenson, and P.M. Lewinsohn An investigation into the observed sex difference in prevalence of unipolar depression J. Abnorm. Psychol. 90 1981 1 13
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013 American Psychiatric Publishing Arilington, VA
6. D.J. Anderson Optogenetics, sex, and violence in the brain: implications for psychiatry Biol. Psychiatry 71 2012 1081 1089
7. S.M. Anderson, and D.H. Brunzell Low dose nicotine and antagonism of beta2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice PLoS One 7 2012 e48665
8. J.T. Andreasen, G.M. Olsen, O. Wiborg, and J.P. Redrobe Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests J. Psychopharmacol. 23 2009 797 804
9. J.T. Andreasen, and J.P. Redrobe Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex Behav. Pharmacol. 20 2009 286 295
10. J.T. Andreasen, J.P. Redrobe, and E.O. Nielsen Combined alpha7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987 Pharmacol. Biochem. Behav. 100 2012 624 629
11. J.T. Andreasen, J.P. Redrobe, E.O. Nielsen, J.K. Christensen, G.M. Olsen, and D. Peters A combined alpha7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances Neuropharmacology 73 2013 183 191
12. L.E. Arnold, M.G. Aman, J. Hollway, E. Hurt, B. Bates, X. Li, C. Farmer, R. Anand, S. Thompson, Y. Ramadan, and C. Williams Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders J. Child Adolesc. Psychopharmacol. 22 2012 198 205
13. I. Bacher, B. Wu, D.R. Shytle, and T.P. George Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders Expert Opin. Pharmacother. 10 2009 2709 2721
14. R.J. Bandler Jr. Facilitation of aggressive behaviour in rat by direct cholinergic stimulation of the hypothalamus Nature 224 1969 1035 1036
15. R.J. Bandler Jr. Cholinergic synapses in the lateral hypothalamus for the control of predatory aggression in the rat Brain Res. 20 1970 409 424
16. M.L. Berk, and J.A. Finkelstein Afferent projections to the preoptic area and hypothalamic regions in the rat brain Neuroscience 6 1981 1601 1624
17. G.G. Berntson, M.S. Beattie, and J.M. Walker Effects of nicotinic and muscarinic compounds on biting attack in the cat Pharmacol. Biochem. Behav. 5 1976 235 239
18. J.M. Boden, D.M. Fergusson, and L.J. Horwood Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort Br. J. Psychiatry 196 2010 440 446
19. B. Borrelli, B. Bock, T. King, B. Pinto, and B.H. Marcus The impact of depression on smoking cessation in women Am. J. Prev. Med. 12 1996 378 387
20. A.L. Brody, M.A. Mandelkern, E.D. London, R.E. Olmstead, J. Farahi, D. Scheibal, J. Jou, V. Allen, E. Tiongson, S.I. Chefer, A.O. Koren, and A.G. Mukhin Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors Arch. Gen. Psychiatry 63 2006 907 915
21. J. Cairney, and T.J. Wade The influence of age on gender differences in depression: further population-based evidence on the relationship between menopause and the sex difference in depression Soc. Psychiatry Psychiatr. Epidemiol. 37 2002 401 408
22. B.J. Caldarone, A. Harrist, M.A. Cleary, R.D. Beech, S.L. King, and M.R. Picciotto High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation Biol. Psychiatry 56 2004 657 664
23. H. Carmel, and B.B. Sheitman Adjunctive transdermal nicotine reduced behavioral agitation in severe dementia Am. J. Geriatr. Psychiatry 15 2007 449
24. J.P. Changeux Nicotine addiction and nicotinic receptors: lessons from genetically modified mice Nat. Rev. Neurosci. 11 2010 389 401
25. S. Cheeta, E.E. Irvine, P.J. Kenny, and S.E. File The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses Psychopharmacology 155 2001 78 85
26. P. Chen, D. Lin, J. Giesler, and C. Li Identification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain J. Comp. Neurol. 519 2011 2023 2042
27. J.W. Coe, P.R. Brooks, M.G. Vetelino, M.C. Wirtz, E.P. Arnold, J. Huang, S.B. Sands, T.I. Davis, L.A. Lebel, C.B. Fox, A. Shrikhande, J.H. Heym, E. Schaeffer, H. Rollema, Y. Lu, R.S. Mansbach, L.K. Chambers, C.C. Rovetti, D.W. Schulz, F.D. Tingley 3rd, and B.T. O'Neill Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation J. Med. Chem. 48 2005 3474 3477
28. C.K. Conners, E.D. Levin, E. Sparrow, S.C. Hinton, D. Erhardt, W.H. Meck, J.E. Rose, and J. March Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD) Psychopharmacol. Bull. 32 1996 67 73
29. J.D. Corrigan Development of a scale for assessment of agitation following traumatic brain injury J. Clin. Exp. Neuropsychol. 11 1989 261 277
30. R.S. Coura, A. Cressant, J. Xia, F. de Chaumont, J.C. Olivo-Marin, Y. Pelloux, J.W. Dalley, and S. Granon Nonaggressive and adapted social cognition is controlled by the interplay between noradrenergic and nicotinic receptor mechanisms in the prefrontal cortex FASEB J. 27 2013 4343 4354
31. L.S. Covey, A.H. Glassman, and F. Stetner Cigarette smoking and major depression J. Addict. Dis. 17 1998 35 46
32. J.N. Crawley, J.K. Belknap, A. Collins, J.C. Crabbe, W. Frankel, N. Henderson, R.J. Hitzemann, S.C. Maxson, L.L. Miner, A.J. Silva, J.M. Wehner, A. Wynshaw-Boris, and R. Paylor Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies Psychopharmacology 132 1997 107 124
33. D.C. D'Souza, K. Ahn, S. Bhakta, J. Elander, N. Singh, H. Nadim, P. Jatlow, R.F. Suckow, B. Pittman, and M. Ranganathan Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia Biol. Psychiatry 72 2012 785 794
34. M.S. D'Souza, and A. Markou Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits Neuropharmacology 62 2012 1564 1573
35. R.J. Davidson, D.A. Lewis, L.B. Alloy, D.G. Amaral, G. Bush, J.D. Cohen, W.C. Drevets, M.J. Farah, J. Kagan, J.L. McClelland, S. Nolen-Hoeksema, and B.S. Peterson Neural and behavioral substrates of mood and mood regulation Biol. Psychiatry 52 2002 478 502
36. A. Diwan, M. Castine, C.S. Pomerleau, J.H. Meador-Woodruff, and G.W. Dalack Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders Schizophr. Res. 33 1998 113 118
37. W. Drevets Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders Curr. Opin. Neurobiol. 11 2001 240 249
38. P. Driscoll, and K. Baettig Selective inhibition by nicotine of shock-induced fighting in the rat Pharmacol. Biochem. Behav. 14 1981 175 179
39. K. Drusch, A. Lowe, K. Fisahn, J. Brinkmeyer, F. Musso, A. Mobascher, T. Warbrick, J. Shah, C. Ohmann, G. Winterer, and W. Wolwer Effects of nicotine on social cognition, social competence and self-reported stress in schizophrenia patients and healthy controls Eur. Arch. Psychiatry Clin. Neurosci. 263 2013 519 527
40. I. Esterlis, J.O. Hannestad, F. Bois, R.A. Sewell, R.F. Tyndale, J.P. Seibyl, M.R. Picciotto, M. Laruelle, R.E. Carson, and K.P. Cosgrove Imaging changes in synaptic acetylcholine availability in living human subjects J. Nucl. Med. 54 2013 78 82
41. K.O. Fagerstrom Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment Addict. Behav. 3 1978 235 241
42. M. Fava, and J.F. Rosenbaum Anger attacks in depression Depress Anxiety 8 Suppl. 1 1998 59 63
43. C.P. Fenster, M.F. Rains, B. Noerager, M.W. Quick, and R.A. Lester Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine J. Neurosci. 17 1997 5747 5759
44. C.P. Fenster, T.L. Whitworth, E.B. Sheffield, M.W. Quick, and R.A. Lester Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine J. Neurosci. 19 1999 4804 4814
45. S.E. File, S. Cheeta, and P.J. Kenny Neurobiological mechanisms by which nicotine mediates different types of anxiety Eur. J. Pharmacol. 393 2000 231 236
46. S.E. File, P.J. Kenny, and S. Cheeta The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety Pharmacol. Biochem. Behav. 66 2000 65 72
47. Y. Fu, S.G. Matta, V.G. Brower, and B.M. Sharp Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: an in vivo microdialysis study J. Neurosci. 21 2001 8979 8989
48. Y. Fu, S.G. Matta, T.J. James, and B.M. Sharp Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors J. Pharmacol. Exp. Ther. 284 1998 1188 1196
49. J. Garduno, L. Galindo-Charles, J. Jimenez-Rodriguez, E. Galarraga, D. Tapia, S. Mihailescu, and S. Hernandez-Lopez Presynaptic alpha4beta2 nicotinic acetylcholine receptors increase glutamate release and serotonin neuron excitability in the dorsal raphe nucleus J. Neurosci. 32 2012 15148 15157
50. T.P. George, K.A. Sacco, J.C. Vessicchio, A.H. Weinberger, and R.D. Shytle Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study J. Clin. Psychopharm. 28 2008 340 344
51. D.G. Gilbert, F.J. McClernon, N.E. Rabinovich, L.C. Plath, R. Jensen, and C.J. Meliska Effects of smoking abstinence on mood and craving in men: influences of negative-affect-related personality traits, habitual nicotine intake and repeated measurements Pers. Individ. Differ. 25 1998 399 423
52. A.H. Glassman, J.E. Helzer, L.S. Covey, L.B. Cottler, F. Stetner, J.E. Tipp, and J. Johnson Smoking, smoking cessation, and major depression Jama 264 1990 1546 1549
53. S.R. Grady, M.J. Marks, and A.C. Collins Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes J. Neurochem. 62 1994 1390 1398
54. Z.Y. Han, N. Le Novère, M. Zoli, J.A. Hill, N. Champtiaux, and J.P. Changeux Localization of nAChR subunit mRNAs in the brain of Macaca mulatta Eur. J. Neurosci. 12 2000 3664 3674
55. D. Hatsukami, J.R. Hughes, and R. Pickens Characterization of tobacco withdrawal: physiological and subjective effects NIDA Res. Monogr. 53 1985 56 67
56. M.J. Hoptman, D. Antonius, C.J. Mauro, E.M. Parker, and D.C. Javitt Cortical thinning, functional connectivity, and mood-related impulsivity in schizophrenia: relationship to aggressive attitudes and behavior Am. J. Psychiatry 171 2014 939 948
57. L. Huang, and U. Winzer-Serhan Nicotine regulates mRNA expression of feeding peptides in the arcuate nucleus in neonatal rat pups Dev. Neurobiol. 67 2007 363 377
58. R. Igic, P. Stern, and E. Basagic Changes in emotional behaviour after application of cholinesterase inhibitor in the septal and amygdala region Neuropharmacology 9 1970 73 75
59. S.K. Johnson, K.M. Carlson, J. Lee, L.E. Burr, and G.C. Wagner Effects of nicotine on target biting and resident-intruder attack Life Sci. 73 2003 311 317
60. P.J. Kenny, S.E. File, and M.J. Neal Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release J. Neurochem. 75 2000 2409 2414
61. G.F. Koob, and M. Le Moal Drug addiction, dysregulation of reward, and allostasis Neuropsychopharmacology 24 2001 97 129
62. M.G. Kushner, E. Maurer, K. Menary, and P. Thuras Vulnerability to the rapid ("telescoped") development of alcohol dependence in individuals with anxiety disorder J. Stud. Alcohol Drugs 72 2011 1019 1027
63. M.G. Kushner, K.R. Menary, E.W. Maurer, and P. Thuras Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder J. Stud. Alcohol Drugs 73 2012 920 924
64. C. Labarca, J. Schwarz, P. Deshpande, S. Schwarz, M.W. Nowak, C. Fonck, R. Nashmi, P. Kofuji, H. Dang, W. Shi, M. Fidan, B.S. Khakh, Z. Chen, B.J. Bowers, J. Boulter, J.M. Wehner, and H.A. Lester Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety Proc. Natl. Acad. Sci. U. S. A. 98 2001 2786 2791
65. R.P. Laje, J.A. Berman, and A.H. Glassman Depression and nicotine: preclinical and clinical evidence for common mechanisms Curr. Psychiatry Rep. 3 2001 470 476
66. J. LeDoux The emotional brain, fear, and the amygdala Cell. Mol. Neurobiol. 23 2003 727 738
67. H. Lee, D.W. Kim, R. Remedios, T.E. Anthony, A. Chang, L. Madisen, H. Zeng, and D.J. Anderson Scalable control of mounting and attack by Esr1+ neurons in the ventromedial hypothalamus Nature 509 2014 627 632
68. X. Li, D.G. Rainnie, R.W. McCarley, and R.W. Greene Presynaptic nicotinic receptors facilitate monoaminergic transmission J. Neurosci. 18 1998 1904 1912
69. D. Lin, M.P. Boyle, P. Dollar, H. Lee, E.S. Lein, P. Perona, and D.J. Anderson Functional identification of an aggression locus in the mouse hypothalamus Nature 470 2011 221 226
70. O. Lucidarme, A. Seguin, C. Daubin, M. Ramakers, N. Terzi, P. Beck, P. Charbonneau, and D. du Cheyron Nicotine withdrawal and agitation in ventilated critically ill patients Crit. Care 14 2010 R58
71. P.G. Luiten, and P. Room Interrelations between lateral, dorsomedial and ventromedial hypothalamic nuclei in the rat. An HRP study Brain Res. 190 1980 321 332
72. H.D. Mansvelder, J.R. Keath, and D.S. McGehee Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas Neuron 33 2002 905 919
73. A. Markou, T.R. Kosten, and G.F. Koob Neurobiological similarities in depression and drug dependence: a self-medication hypothesis Neuropsychopharmacology 18 1998 135 174
74. M.J. Marks, J.B. Burch, and A.C. Collins Genetics of nicotine response in four inbred strains of mice J. Pharm. Exp. Ther. 226 1983 291 302
75. M.J. Marks, E. Romm, D.K. Gaffney, and A.C. Collins Nicotine-induced tolerance and receptor changes in four mouse strains J. Pharmacol. Exp. Ther. 237 1986 809 819
76. U. Maskos, B.E. Molles, S. Pons, M. Besson, B.P. Guiard, J.P. Guilloux, A. Evrard, P. Cazala, A. Cormier, M. Mameli-Engvall, N. Dufour, I. Cloez-Tayarani, A.P. Bemelmans, J. Mallet, A.M. Gardier, V. David, P. Faure, S. Granon, and J.P. Changeux Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors Nature 436 2005 103 107
77. S.G. Matta, Y. Fu, J.D. Valentine, and B.M. Sharp Response of the hypothalamo-pituitary-adrenal axis to nicotine Psychoneuroendocrinology 23 1998 103 113
78. S.A. Mayer, J.Y. Chong, E. Ridgway, K.C. Min, C. Commichau, and G.L. Bernardini Delirium from nicotine withdrawal in neuro-ICU patients Neurology 57 2001 551 553
79. F.J. McClernon, F.B. Hiott, E.C. Westman, J.E. Rose, and E.D. Levin Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial Psychophamacology 189 2006 125 133
80. T.M. McGranahan, N.E. Patzlaff, S.R. Grady, S.F. Heinemann, and T.K. Booker alpha4beta2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief J. Neurosci. 31 2011 10891 10902
81. D.M. McNair, M. Lorr, and L.F. Droppleman Manual for the Profile of Mood States 1971 Educational and Industrial Testing Services San Diego, CA
82. J.H. Mendelson, M.B. Sholar, N. Goletiani, A.J. Siegel, and N.K. Mello Effects of low- and high-nicotine cigarette smoking on mood states and the HPA axis in men Neuropsychopharmacology 30 2005 1751 1763
83. S.C. Messer, and A.M. Gross Childhood depression and aggression: a covariance structure analysis Behav. Res. Ther. 32 1994 663 677
84. S. Mihailescu, M. Palomerorivero, P. Meadehuerta, A. Mazaflores, and R. Druckercolin Effects of nicotine and mecamylamine on rat dorsal raphe neurons Eur. J. Pharmacol. 360 1998 31 36
85. Y.S. Mineur, C. Eibl, G. Young, C. Kochevar, R.L. Papke, D. Gundisch, and M.R. Picciotto Cytisine-based nicotinic partial agonists as novel antidepressant compounds J. Pharmacol. Exp. Ther. 329 2009 377 386
86. Y.S. Mineur, E.B. Einstein, M.P. Bentham, M.B. Wigestrand, S. Blakeman, S.A. Newbold, and M.R. Picciotto Expression of the 5-HT1A serotonin receptor in the hippocampus is required for social stress resilience and the antidepressant-like effects induced by the nicotinic partial agonist cytisine Neuropsychopharmacology (advance online publication) October 29, 2014 10.1038/npp.2014.269
87. Y.S. Mineur, E.B. Einstein, P.A. Seymour, J.W. Coe, B.T. O'Neill, H. Rollema, and M.R. Picciotto alpha4beta2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties Behav. Pharmacol. 22 2011 291 299
88. Y.S. Mineur, A. Obayemi, M.B. Wigestrand, G.M. Fote, C.A. Calarco, A.M. Li, and M.R. Picciotto Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior Proc. Natl. Acad. Sci. U. S. A. 110 2013 3573 3578
89. Y.S. Mineur, and M.R. Picciotto Biological basis for the co-morbidity between smoking and mood disorders J. Dual Diagn. 5 2009 1 9
90. Y.S. Mineur, and M.R. Picciotto Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis Trends Pharmacol. Sci. 31 2010 580 586
91. Y.S. Mineur, O. Somenzi, and M.R. Picciotto Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice Neuropharmacology 52 2007 1256 1262
92. I. Morganstern, O. Lukatskaya, S.H. Moon, W.R. Guo, J. Shaji, O. Karatayev, and S.F. Leibowitz Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet Psychopharmacol. (Berl.) 230 2013 509 524
93. S.B. Morissette, M.T. Tull, S.B. Gulliver, B.W. Kamholz, and R.T. Zimering Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships Psychol. Bull. 133 2007 245 272
94. S. Moylan, F.N. Jacka, J.A. Pasco, and M. Berk Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies BMC Med. 10 2012 123
95. R.J. Nelson, and B.C. Trainor Neural mechanisms of aggression Nat. Rev. Neurosci. 8 2007 536 546
96. E.J. Nestler Epigenetic mechanisms of depression JAMA Psychiatry 71 2014 454 456
97. E.J. Nestler, and W.A. Carlezon Jr. The mesolimbic dopamine reward circuit in depression Biol. Psychiatry 59 2006 1151 1159
98. P.A. Newhouse, A. Potter, J. Corwin, and R. Lenox Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior Neuropsychopharmacology 10 1994 93 107
99. C. Oncken, D. Gonzales, M. Nides, S. Rennard, E. Watsky, C.B. Billing, R. Anziano, and K. Reeves Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation Arch. Intern. Med. 166 2006 1571 1577
100. D.J. Parrott, and A. Zeichner Effects of nicotine deprivation and irritability on physical aggression in male smokers Psychol. Addict. Behav. 15 2001 133 139
101. P. Pervanidou Biology of post-traumatic stress disorder in childhood and adolescence J. Neuroendocrinol. 20 2008 632 638
102. N.S. Philip, L.L. Carpenter, A.R. Tyrka, L.B. Whiteley, and L.H. Price Varenicline augmentation in depressed smokers: an 8-week, open-label study J. Clin. Psychiatry 70 2009 1026 1031
103. M. Picciotto, N. Addy, Y. Mineur, and D. Brunzell It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood Prog. Neurobiol. 84 2008 329 342
104. M.R. Picciotto, D.H. Brunzell, and B.J. Caldarone Effect of nicotine and nicotinic receptors on anxiety and depression Neuroreport 13 2002 1097 1106
105. M.R. Picciotto, M.J. Higley, and Y.S. Mineur Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior Neuron 76 2012 116 129
106. V.I. Pidoplichko, E.M. Prager, V. Aroniadou-Anderjaska, and M.F. Braga alpha7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability J. Neurophysiol. 110 2013 2358 2369
107. R. Radhakrishnan, A. Santamaria, L. Escobar, and H.R. Arias The beta4 nicotinic receptor subunit modulates the chronic antidepressant effect mediated by bupropion Neurosci. Lett. 555 2013 68 72
108. E.J. Ramos, M.M. Meguid, L. Zhang, G. Miyata, S.O. Fetissov, C. Chen, S. Suzuki, and A. Laviano Nicotine infusion into rat ventromedial nuclei and effects on monoaminergic system Neuroreport 15 2004 2293 2297
109. R. Redolat, M.C. Oterino, M.C. Carrasco, M.S. Berry, and P.F. Brain Effects of acute administration of nicotine and lobeline on agonistic encounters in male mice Aggress. Behav. 26 2000 376 385
110. S.C. Risch, R.M. Cohen, D.S. Janowsky, N.H. Kalin, and D.L. Murphy Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol Science 209 1980 1545 1546
111. R.J. Rodgers Effects of nicotine, mecamylamine, and hexamethonium on shock-induced fighting, pain reactivity, and locomotor behaviour in rats Psychopharmacol. (Berl.) 66 1979 93 98
112. T.A. Roeling, J.G. Veening, M.R. Kruk, J.P. Peters, M.E. Vermelis, and R. Nieuwenhuys Efferent connections of the hypothalamic "aggression area" in the rat Neuroscience 59 1994 1001 1024
113. Z. Rolinski, and M. Herbut The importance of central nicotinic receptors in footshock-induced aggression in mice Pol. J. Pharmacol. Pharm. 33 1981 569 576
114. H. Rollema, L.K. Chambers, J.W. Coe, J. Glowa, R.S. Hurst, L.A. Lebel, Y. Lu, R.S. Mansbach, R.J. Mather, C.C. Rovetti, S.B. Sands, E. Schaeffer, D.W. Schulz, F.D. Tingley, and K.E. Williams Pharmacological profile of the alpha(4)beta(2) nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 52 2007 985 994
115. H. Rollema, V. Guanowsky, Y. Mineur, A. Shrikhande, J. Coe, P. Seymour, and M. Picciotto Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect Eur. J. Pharmacol. 605 2009 114 116
116. R.A. Rosin, M.D. Levine, and E. Peskind Transdermal nicotine for agitation in dementia Am. J. Geriatr. Psychiatry 9 2001 443 444
117. R.J. Salin-Pascual, J.R. de la Fuente, L. Galicia-Polo, and R. Drucker-Colin Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients Psychopharmacology 121 1995 476 479
118. R.J. Salin-Pascual, M. Rosas, A. Jiminez Genchi, B.L. Rivera Meza, and V. Delgado Parra Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression J. Clin. Psychiatry 57 1996 387 389
119. L. Santarelli, M. Saxe, C. Gross, A. Surget, F. Battaglia, S. Dulawa, N. Weisstaub, J. Lee, R. Duman, O. Arancio, C. Belzung, and R. Hen Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 805 809
120. A. Saricicek, I. Esterlis, K.H. Maloney, Y.S. Mineur, B.M. Ruf, A. Muralidharan, J.I. Chen, K.P. Cosgrove, R. Kerestes, S. Ghose, C.A. Tamminga, B. Pittman, F. Bois, G. Tamagnan, J. Seibyl, M.R. Picciotto, J.K. Staley, and Z. Bhagwagar Persistent beta2∗-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder Am. J. Psychiatry 169 2012 851 859
121. M.A. Schechter Nicotine replacement therapy in the psychiatric emergency department Am. J. Psychiatry 168 2011 347 349
122. M.D. Schechter Effect of nicotine on response to frustrative non-reward in the rat Eur. J. Pharmacol. 29 1974 312 315
123. P. Seth, S. Cheeta, S. Tucci, and S.E. File Nicotinic-serotonergic interactions in brain and behaviour Pharmacol. Biochem. Behav. 71 2002 795 805
124. R.D. Shytle, A.A. Silver, R.J. Lukas, M.B. Newman, D.V. Sheehan, and P.R. Sanberg Nicotinic acetylcholine receptors as targets for antidepressants Mol. Psychiatry 7 2002 525 535
125. A. Siegel, T.A. Roeling, T.R. Gregg, and M.R. Kruk Neuropharmacology of brain-stimulation-evoked aggression Neurosci. Biobehav. Rev. 23 1999 359 389
126. A.A. Silver, R.D. Shytle, M.K. Philipp, B.J. Wilkinson, B. McConville, and P.R. Sanberg Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study J. Clin. Psychiatry 62 2001 707 714
127. A.A. Silver, R.D. Shytle, and P.R. Sanberg Mecamylamine in Tourette's syndrome: a two-year retrospective case study J. Child Adolesc. Psychopharmacol. 10 2000 59 68
128. A.A. Silver, R.D. Shytle, K.H. Sheehan, D.V. Sheehan, A. Ramos, and P.R. Sanberg Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder J. Am. Acad. Child Adolesc. Psychiatry 40 2001 1103 1110
129. A.P. Silverman Behaviour of rats given a "smoking dose" of nicotine Anim. Behav. 19 1971 67 74
130. J.E. Slemmer, B.R. Martin, and M.I. Damaj Bupropion is a nicotinic antagonist J. Pharmacol. Exp. Ther. 295 2000 321 327
131. R.P. Snaith, and C.M. Taylor Irritability: definition, assessment and associated factors Br. J. Psychiatry 147 1985 127 136
132. A.K. Stoker, and A. Markou Unraveling the neurobiology of nicotine dependence using genetically engineered mice Curr. Opin. Neurobiol. 23 2013 493 499
133. A.C. Swann Neuroreceptor mechanisms of aggression and its treatment J. Clin. Psychiatry 64 Suppl. 4 2003 26 35
134. A. Takahashi, I.M. Quadros, R.M. de Almeida, and K.A. Miczek Behavioral and Pharmacogenetics of aggressive behavior Curr. Top. Behav. Neurosci. 12 2012 73 138
135. A. Takahashi, A.N. Schilit, J. Kim, J.F. Debold, T. Koide, and K.A. Miczek Behavioral characterization of escalated aggression induced by GABA(B) receptor activation in the dorsal raphe nucleus Psychopharmacol. (Berl.) 224 2012 155 166
136. Y. Tizabi, D.H. Overstreet, A.H. Rezvani, V.A. Louis, E. Clark Jr., D.S. Janowsky, and M.A. Kling Antidepressant effects of nicotine in an animal model of depression Psychopharmacologia 142 1999 193 199
137. Y. Tizabi, A.H. Rezvani, L.T. Russell, K.Y. Tyler, and D.H. Overstreet Depressive characteristics of FSL rats: involvement of central nicotinic receptors Pharmacol. Biochem. Behav. 66 2000 73 77
138. S. Tolu, R. Eddine, F. Marti, V. David, M. Graupner, S. Pons, M. Baudonnat, M. Husson, M. Besson, C. Reperant, J. Zemdegs, C. Pages, Y.A. Hay, B. Lambolez, J. Caboche, B. Gutkin, A.M. Gardier, J.P. Changeux, P. Faure, and U. Maskos Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement Mol. Psychiatry 18 3 2012 382 393
139. E. Tribollet, D. Bertrand, A. Marguerat, and M. Raggenbass Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain Neuroscience 124 2004 405 420
140. E. Vieta, M.E. Thase, D. Naber, B. D'Souza, E. Rancans, U. Lepola, B. Olausson, J. Szamosi, E. Wilson, D. Hosford, G. Dunbar, R. Tummala, and H. Eriksson Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant Eur. Neuropsychopharmacol. 24 2014 564 574
141. R.J. Waldbillig Suppressive effects of intraperitoneal and intraventricular injections of nicotine on muricide and shock-induced attack on conspecifics Pharmacol. Biochem. Behav. 12 1980 619 623
142. K.D. Ward, R.C. Klesges, S.M. Zbikowski, R.E. Bliss, and A.J. Garvey Gender differences in the outcome of an unaided smoking cessation attempt Addict. Behav. 22 1997 521 533
143. J.L. Warner-Schmidt, E.F. Schmidt, J.J. Marshall, A.J. Rubin, M. Arango-Lievano, M.G. Kaplitt, I. Ibanez-Tallon, N. Heintz, and P. Greengard Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior Proc. Natl. Acad. Sci. U. S. A. 109 2012 11360 11365
144. S.S. Watkins, G.F. Koob, and A. Markou Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal Nicotine Tob. Res. 2 2000 19 37
145. B. Weiss, and T. Catron Specificity of the comorbidity of aggression and depression in children J. Abnorm. Child Psychol. 22 1994 389 401
146. P.J. Whalen, B.S. Kapp, and J.P. Pascoe Neuronal activity within the nucleus basalis and conditioned neocortical electroencephalographic activation J. Neurosci. 14 1994 1623 1633
147. R. Yanowitch, and E.F. Coccaro The neurochemistry of human aggression Adv. Genet. 75 2011 151 169
148. B.C. Yoburn, and M. Glusman The effects of intrahypothalamic hemicholinium-3 on muricide, irritability and feeding Pharmacol. Biochem. Behav. 20 1984 829 833